4.5 Article

Sex Differences in Outcome after Mild Traumatic Brain Injury

期刊

JOURNAL OF NEUROTRAUMA
卷 27, 期 3, 页码 527-539

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/neu.2009.1068

关键词

mild traumatic brain injury; outcome; post-concussive symptoms; sex; unemployment

资金

  1. National Institutes of Neurologic Disorders and Stroke [1K23NS41952]
  2. National Center for Research Resources (NCRR) [5 MO1 RR00044]
  3. National Institutes of Health (NIH)

向作者/读者索取更多资源

The objective of this study was to estimate the independent association of sex with outcome after mild traumatic brain injury (mTBI). We performed an analysis of a subset of an established cohort involving 1425 mTBI patients presenting to an academic emergency department (ED). The associations between sex and three outcomes determined 3 months after the initial ED visit were examined: post-concussive symptom (PCS) score ( 0, 1-5, 6-16, and >16), the number of days to return of normal activities (0, 1-7, and >7), and the number of days of work missed (0, 1-7, and >7). Logistic regression analyses were used to determine the relationship between sex and each outcome after controlling for 12 relevant subject-level variables. Of the 1425 subjects, 643 (45.1%) were female and 782 (54.9%) were male. Three months after mTBI, males had significantly lower odds of being in a higher PCS score category (odds ratio [ OR] 0.62, 95% confidence interval [CI]: 0.50, 0.78); this association appeared to be more prominent during child-bearing years for females. Males and females did not significantly differ with respect to the odds of poorer outcome as defined by the number of days to return of normal activities or the number of days of work missed. Female sex is associated with significantly higher odds of poor outcome after mTBI, as measured by PCS score, after control for appropriate confounders. The observed pattern of peak disability for females during the child-bearing years suggests disruption of endogenous estrogen or progesterone production. Attempts to better understand how mTBI affects production of these hormones acutely after injury and during the recovery period may shed light on the mechanism behind poorer outcome among females and putative therapeutic interventions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Analysis of potential time saving in brain arteriovenous malformation stereotactic radiosurgery planning using a new software platform

Guilherme Dabus, Rupesh Kotecha, Italo Linfante, D. Jay Wieczorek, Alonso N. Gutierrez, John G. Candela, Michael W. McDermott

Summary: This study aimed to evaluate the utility of integrating a 3D vessel tree co-registration software platform into the treatment of brain arteriovenous malformation (bAVM) and its time-saving effect. The results showed that using this software platform can significantly save time in the treatment process, which is of great importance for the treatment of bAVMs.

MEDICAL DOSIMETRY (2022)

Article Mathematical & Computational Biology

Adaptive dose-response studies to establish proof-of-concept in learning-phase clinical trials

Shiyang Ma, Michael P. McDermott

Summary: Adaptive designs in learning-phase clinical trials can be efficient and highly informative. This article extends the MCP-Mod procedure with GMCTs for two-stage adaptive designs for proof-of-concept. The results of an interim analysis guide adaptations to candidate dose-response models and dosages studied in the second stage, with GMCTs used in both stages to obtain and combine stage-wise p-values for an overall p-value. Simulation studies show advantages of adaptive designs over nonadaptive designs when candidate dose-response models are not well-informed by preclinical and early-phase evidence.

BIOMETRICAL JOURNAL (2022)

Review Clinical Neurology

Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases

Michael Benatar, Joanne Wuu, Caroline McHutchison, Ronald B. Postuma, Bradley F. Boeve, Ronald Petersen, Christopher A. Ross, Howard Rosen, Jalayne J. Arias, Stephanie Fradette, Michael P. McDermott, Jeremy Shefner, Christine Stanislaw, Sharon Abrahams, Stephanie Cosentino, Peter M. Andersen, Richard S. Finkel, Volkan Granit, Anne-Laure Grignon, Jonathan D. Rohrer, Corey T. McMillan, Murray Grossman, Ammar Al-Chalabi, Martin R. Turner

Summary: Significant progress has been made in understanding the pre-symptomatic phase of amyotrophic lateral sclerosis. Advances in other neurodegenerative diseases provide valuable insights and highlight opportunities for discovery in ALS. Biomarkers play a critical role in studying pre-symptomatic ALS and are essential for early therapeutic intervention and disease prevention.
Review Cardiac & Cardiovascular Systems

Patient-Reported Outcome Measures in Symptomatic, Non-Limb-Threatening Peripheral Artery Disease: A State-of-the-Art Review

Jennifer A. Rymer, Dennis Narcisse, Michael Cosiano, John Tanaka, Mary M. McDermott, Diane J. Treat-Jacobson, Michael S. Conte, Brandi Tuttle, Manesh R. Patel, Kim G. Smolderen

Summary: This review summarizes the validation of patient-reported outcome measures (PROMs) in people with symptomatic peripheral artery disease. The findings suggest that disease-specific PROMs have good reliability and sensitivity, while generic PROMs have more extensive validation evidence. These findings can guide the selection of PROMs aligned with scientific and clinical goals.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2022)

Meeting Abstract Gastroenterology & Hepatology

DEVELOPMENT AND VALIDATION OF THE CROHN'S DISEASE-HEALTH INDEX (CD-HI), A CLINICALLY-RELEVANT, DISEASE-SPECIFIC PATIENT-REPORTED OUTCOME MEASURE

Jamison Seabury, Jennifer Weinstein, Spencer Rosero, Anika Varma, Ellen Wagner, Christine Zizzi, Nuran Dilek, Michael McDermott, Aaron Kaat, Lawrence Saubermann, Larissa Temple, Scott Rogoff, Chad Heatwole, Zach Rose

INFLAMMATORY BOWEL DISEASES (2022)

Correction Gastroenterology & Hepatology

P047 The Crohn's Disease-Health Index (CD-HI): Development and Validation of a Novel, Disease-Specific Patient-Reported Outcome Measure for Clinical Trials (vol 116, pg S12, 2021)

Jamison Seabury, Jennifer Weinstein, Spencer Rosero, Anika Varma, Ellen Wagner, Christine Zizzi, Nuran Dilek, Michael McDermott, Aaron Kaat, Lawrence Saubermann, Larissa Temple, Scott Rogoff, Chad Heatwole

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Editorial Material Medicine, General & Internal

Home-Based Walking Exercise for Peripheral Artery Disease

Mary M. McDermott

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Medicine, General & Internal

Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy A Randomized Clinical Trial

Michela Guglieri, Kate Bushby, Michael P. McDermott, Kimberly A. Hart, Rabi Tawil, William B. Martens, Barbara E. Herr, Elaine McColl, Chris Speed, Jennifer Wilkinson, Janbernd Kirschner, Wendy M. King, Michelle Eagle, Mary W. Brown, Tracey Willis, Robert C. Griggs

Summary: A double-blind, parallel-group randomized clinical trial was conducted to compare the efficacy and adverse effects of different corticosteroid regimens in boys with Duchenne muscular dystrophy. The study found that daily prednisone and daily deflazacort were more effective than intermittent prednisone for improving motor function, pulmonary function, and satisfaction with treatment over a 3-year period. There was no significant difference between the two daily corticosteroid regimens.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Genetics & Heredity

Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities

Abrar Choudhury, Stephen T. Magill, Charlotte D. Eaton, Briana C. Prager, William C. Chen, Martha A. Cady, Kyounghee Seo, Calixto-Hope G. Lucas, Tim J. Casey-Clyde, Harish N. Vasudevan, S. John Liu, Javier E. Villanueva-Meyer, Tai-Chung Lam, Jenny Kan-Suen Pu, Lai-Fung Li, Gilberto Ka-Kit Leung, Danielle L. Swaney, Michael Y. Zhang, Jason W. Chan, Zhixin Qiu, Michael V. Martin, Matthew S. Susko, Steve E. Braunstein, Nancy Ann Oberheim Bush, Jessica D. Schulte, Nicholas Butowski, Penny K. Sneed, Mitchel S. Berger, Nevan J. Krogan, Arie Perry, Joanna J. Phillips, David A. Solomon, Joseph F. Costello, Michael W. McDermott, Jeremy N. Rich, David R. Raleigh

Summary: DNA methylation profiling identified three groups of meningiomas with distinct clinical outcomes, biological drivers, and therapeutic vulnerabilities. Cytostatic cell cycle inhibitors showed efficacy in attenuating meningioma growth.

NATURE GENETICS (2022)

Article Clinical Neurology

Surgery, Stereotactic Radiosurgery, and Systemic Therapy in the Management of Operable Brain Metastasis

Rupesh Kotecha, Manmeet S. Ahluwalia, Vitaly Siomin, Michael W. McDermott

Summary: Brain metastases are the most common brain tumors in adults. Recent advances in understanding molecular biology have allowed for tailored systemic therapies and immunotherapies as treatment options. Improved surgical techniques and innovative radiotherapy approaches have also enhanced patient outcomes. Multidisciplinary care is crucial in managing operable patients with brain metastases in the modern era.

NEUROLOGIC CLINICS (2022)

Article Clinical Neurology

Functional outcome measures in young, steroid-naive boys with Duchenne muscular dystrophy

Anna G. Mayhew, Dionne Moat, Michael P. McDermott, Michelle Eagle, Robert C. Griggs, Wendy M. King, Meredith K. James, Robert Muni-Lofra, Alison Shillington, Sarah Gregson, Lindsey Pallant, Christy Skura, Loretta A. Staudt, Katy Eichinger, Heather McMurchie, Rosanna Rabb, Marina Di Marco, Sarah Brown, Riccardo Zanin, Maria Teresa Arnoldi, Melissa McIntyre, Amelia Wilson, Lindsay N. Alfano, Linda P. Lowes, Colleen Blomgren, Evelin Milev, Mario Iodice, Amy Pasternak, Angela Chiu, Ilka Lehnert, Nicole Claus, Kathy A. Dieruf, Enrica Rolle, Alina Nicorici, Barbara Andres, Elke Hobbiebrunken, Gerda Roetmann, Victoria Kern, Matthew Civitello, Sibylle Vogt, Melissa J. Hayes, Cheryl Scholtes, Catherine Lacroix, Tara Gunn, Sinead Warner, Jennifer Newman, Andrea Barp, Katherine Kundrat, Staci Kovelman, Penny J. Powers, Michela Guglieri

Summary: The purpose of this study was to quantify motor performance in genetically confirmed steroid-naive boys with Duchenne muscular dystrophy (DMD), evaluate the test-retest reliability of measures of motor performance in young DMD boys, and assess correlations among different functional outcomes. The study found that physiotherapy measures are reliable in a young, steroid-naive population and rise from floor velocity appears to be a sensitive measure of strength in this population.

NEUROMUSCULAR DISORDERS (2022)

Article Oncology

Inhibition of IRE1 RNase activity modulates tumor cell progression and enhances the response to chemotherapy in colorectal cancer

Sana Abbasi, Helia Rivand, Fatemeh Eshaghi, Mohammad Amin Moosavi, Saeid Amanpour, Michael F. Mcdermott, Marveh Rahmati

Summary: This study aimed to sensitize colorectal cancer cells to chemotherapy by targeting the IRE1a/XBP1 pathway. The results showed that the IRE1a inhibitor 4 mu 8C inhibited CRC cell growth and enhanced the cytotoxicity of 5-FU. In vivo experiments demonstrated that 4 mu 8C inhibited tumor growth and significantly enhanced drug responses when combined with 5-FU.

MEDICAL ONCOLOGY (2023)

Letter Hematology

Recovery of Bone Marrow Function in VEXAS Syndrome-potential Role for Romiplostim

Adam Al-Hakim, Alyssa Cull, Joanna Topping, Fatima Nadat, Joanna Milek, Razan F. Alhefzi, Michael F. McDermott, Roger Owen, Catherine Cargo, James G. Poulter, David G. Kent, Sinisa Savic, ImmunAID Consortium

HEMASPHERE (2023)

Review Clinical Neurology

Posterior petrous face meningiomas presenting with Meniere's-like syndrome: a case series and review of the literature

Ramin A. Morshed, Nicole T. Jiam, Elaina J. Wang, Stephen T. Magill, Renata M. Knoll, Elliott D. Kozin, Philip Theodosopoulos, Steven W. Cheung, Jeffrey D. Sharon, Michael W. McDermott

Summary: This study found that posterior fossa meningiomas involving the endolymphatic sac can cause Meniere's syndrome. Early recognition and microsurgical excision of these tumors are crucial for relieving most symptoms and stabilizing hearing loss.

JOURNAL OF NEUROSURGERY (2022)

Article Clinical Neurology

Adverse radiation effects in volume-staged radiosurgery for large arteriovenous malformations: a multiinstitutional study

Zachary A. Seymour, Jason W. Chan, Michael W. McDermott, Inga Grills, Hong Ye, Hideyuki Kano, Craig A. Lehocky, Rachel C. Jacobs, L. Dade Lunsford, Tomas Chytka, Roman Liscak, Cheng-Chia Lee, Huai-Che Yang, Dale Ding, Jason P. Sheehan, Caleb E. Feliciano, Rafael Rodriguez-Mercado, Veronica L. Chiang, Judith A. Hess, Samuel Sommaruga, Brendan McShane, John Y. K. Lee, Lucas T. Vasas, Anthony M. Kaufmann, Penny K. Sneed

Summary: The study is a multicentered retrospective review of 257 patients treated with volume-staged stereotactic radiosurgery (VS-SRS) for arteriovenous malformations (AVMs). The results showed that size remains the dominant predictor of toxicity following SRS, but overall rates of symptomatic adverse radiation effects (AREs) were lower than anticipated, suggesting dissociation of dose and size through volume staging. Further techniques need to be assessed to optimize outcomes.

JOURNAL OF NEUROSURGERY (2022)

暂无数据